Efficacy and safety of filgotinib in methotrexate-naive patients with rheumatoid arthritis with poor prognostic factors: post hoc analysis of FINCH 3.
Daniel AletahaRené WesthovensCecile Gaujoux-VialaGiovanni AdamiAlan MatsumotoPaul BirdOsvaldo Daniel MessinaMaya H BuchBeatrix BartokZhaoyu YinYing GuoThijs HendrikxGerd-Rüdiger R BurmesterPublished in: RMD open (2021)
FIL200 + MTX efficacy and safety in patients with multiple PPFs were similar to the overall population.